Edition:
United States

BioCryst Pharmaceuticals Inc (BCRX.OQ)

BCRX.OQ on NASDAQ Stock Exchange Global Select Market

4.96USD
16 Feb 2018
Change (% chg)

-- (--)
Prev Close
$4.96
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
308,866
52-wk High
$9.25
52-wk Low
$3.95

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 8.76 -0.181
Jun '17 3.10 -0.210
Mar '17 9.44 -0.189
FY 2016 Dec '16 8.98 -0.061
Sep '16 7.76 -0.156
Jun '16 4.79 -0.221
Mar '16 4.82 -0.310
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-18 3 1.87 4.00 0.10 0.00
Quarter Ending Jun-18 3 1.83 4.00 0.00 0.00
Year Ending Dec-18 9 20.89 35.19 0.10 16.85
Earnings (per share)
Quarter Ending Mar-18 3 -0.23 -0.20 -0.28 -0.25
Quarter Ending Jun-18 3 -0.24 -0.20 -0.32 -0.25
Year Ending Dec-18 9 -0.81 -0.58 -1.33 -0.92
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 180.40 35.76
P/E High - Last 5 Yrs. -- 281.08 46.66
P/E Low - Last 5 Yrs. -- 92.01 24.18
Beta 2.68 0.81 0.81
Price to Sales (TTM) 16.12 141.46 8.59
Price to Book (MRQ) 4.85 19.13 5.23
Price to Tangible Book (MRQ) 4.85 25.71 6.37
Price to Cash Flow (TTM) -- 120.28 26.13
% Owned Institutions 92.69 12.01 2.31

Dividends

  Company industry sector
Dividend Yield -- 0.29 1.50
Dividend Yield - 5 Year Avg 0.00 0.20 2.01
Dividend 5 Year Growth Rate -- 1.84 5.25
Payout Ratio(TTM) -- 8.47 44.77

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 12.84 43.81 9.62
Sales (TTM) vs TTM 1 Yr. Ago 37.81 45.25 7.31
Sales - 5 Yr. Growth Rate 6.05 32.48 10.20
EPS (MRQ) vs Qtr. 1 Yr. Ago -15.82 6.77 18.60
EPS (TTM) vs TTM 1 Yr. Ago 31.39 -- --
EPS - 5 Yr. Growth Rate -- 45.74 11.47
Capital Spending - 5 Yr. Growth Rate 149.12 41.90 14.75

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 2.53 1.77 2.43
Current Ratio (MRQ) 2.53 6.14 3.39
LT Debt to Equity (MRQ) 21.02 16.68 11.95
Total Debt to Equity (MRQ) 54.18 18.86 15.32
Interest Coverage (TTM) -5.16 -165.00 38.67

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 47.24 50.66 54.89
Gross Margin - 5 Yr. Avg. 97.22 55.48 52.59
EBITD Margin (TTM) -155.37 -- --
EBITD - 5 Yr. Avg -147.83 -563.40 10.03
Operating Margin (TTM) -157.66 -589.85 2.96
Operating Margin - 5 Yr. Avg. -150.50 -584.40 5.27
Pre-Tax Margin (TTM) -167.58 -559.39 3.78
Pre-Tax Margin - 5 Yr. Avg. -161.21 -592.51 5.53
Net Profit Margin (TTM) -167.58 -554.46 0.26
Net Profit Margin - 5 Yr. Avg. -161.21 -596.29 1.79
Effective Tax Rate (TTM) -- -0.06 22.06
Effective Tax Rate - 5 Yr. Avg. -- 17.84 24.20

Efficiency

  Company industry sector
Revenue/Employee (TTM) 465,831 23,379,765 824,372,705
Net Income/Employee (TTM) -780,646 -413,169 96,444,553
Receivable Turnover (TTM) 4.05 14.82 5.41
Inventory Turnover (TTM) 3.08 2.46 3.49
Asset Turnover (TTM) 0.21 0.39 0.90

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -35.86 -0.92 10.73
Return on Assets - 5 Yr. Avg. -47.07 -0.52 12.02
Return on Investment (TTM) -62.55 -0.52 13.59
Return on Investment - 5 Yr. Avg. -82.00 2.04 15.73
Return on Equity (TTM) -97.00 -3.30 15.20
Return on Equity - 5 Yr. Avg. -163.53 -2.17 16.95
  1 Year 3 Year 5 Year
Sales % -45.39 14.99 6.05
EPS (TTM) % -26.80 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for BioCryst Pharmaceuticals Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -11.27 -8.73 28 61
13 Week 9.73 3.57 60 91
26 Week 20.98 7.40 63 87
52 Week -24.62 -35.24 35 88
YTD 1.02 -1.15 50 91
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 95.46%
# of Holders: 163
Total Shares Held: 93,939,688
3 Mo. Net Change: 6,326,177
# New Positions: 19
# Closed Positions: 27
# Increased Positions: 82
# Reduced Positions: 57
# Net Buyers: 25
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.